Quarterly report pursuant to Section 13 or 15(d)

ACCOUNTS PAYABLE AND ACCRUED LIABILITIES

v3.24.1.1.u2
ACCOUNTS PAYABLE AND ACCRUED LIABILITIES
 3 Months Ended
Mar. 31, 2024
Payables and Accruals [Abstract]  
ACCOUNTS PAYABLE AND ACCRUED LIABILITIES

NOTE 6. ACCOUNTS PAYABLE AND ACCRUED LIABILITIES

 

The Company’s accounts payable and accrued liabilities consist of the following:

 

    March 31, 2024     December 31, 2023  
Accounts payable   £ 1,927,612     £ 1,847,279  
Other tax and social security     290,255       139,029  
Accrued expenses     1,013,162       1,229,419  
Amounts accrued in respect to clinical trial testing     1,177,500       1,177,500  
Other payables     44,918       38,613  
Total   £ 4,453,447     £ 4,431,840  

 

The fair value of accounts payable and accrued expenses are not materially different to the book value.